Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14974722 | 0.95 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL29104749 | 0.85 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL3620591 | 0.84 | PTGS1 (0.39) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL11979583 | 0.83 | APP (0.42) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL16045492 | 0.81 | APP (0.41) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL5014277 | 0.79 | APP (0.39) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL576422 | 0.79 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL29170917 | 0.78 | APP (0.42) | APPPTGS1PDE4ALMNASLC6A6 | |
| Eprodisate SCHEMBL34216 | 0.78 | APP (0.65) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL25630359 | 0.77 | APP (0.46) | APPPTGS1PDE4ALMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12129239-B2 | Method for producing methylene disulfonate compound | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2024-10-29 | — | — | US | disclosed |
| CN-114144407-B | Process for producing cyclic disulfonate compound | 住友精化株式会社 | 2024-02-13 | — | — | CN | disclosed |
| CN-111971841-B | Nonaqueous electrolyte for electricity storage device | 富山药品工业株式会社 | 2023-09-19 | — | — | CN | disclosed |
| CN-115066421-A | Method for producing methylene disulfonate compound | 住友精化株式会社 | 2022-09-16 | — | — | CN | disclosed |
| EP-4006019-A1 | METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND | Sumitomo Seika Chemicals Co., Ltd. (JP) | 2022-06-01 | — | — | EP | disclosed |
| CN-114144407-A | Process for producing cyclic disulfonate compound | 住友精化株式会社 | 2022-03-04 | — | — | CN | disclosed |
| CN-114144406-A | Method for producing methylene disulfonate compound | 住友精化株式会社 | 2022-03-04 | — | — | CN | disclosed |
| WO-2021161943-A1 | METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND | 住友精化株式会社 | 2021-08-19 | — | — | WO | disclosed |
| WO-2021015219-A1 | METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND | 住友精化株式会社 | 2021-01-28 | — | — | WO | disclosed |
| EP-2610250-B1 | METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND | SUMITOMO SEIKA CHEMICALS (JP) | 2016-01-20 | — | — | EP | disclosed |
| US-8501966-B2 | Method for producing a methylene disulfonate compound | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2013-08-06 | — | — | US | disclosed |
| EP-2610250-A1 | METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND | Sumitomo Seika Chemicals Co. Ltd. (JP) | 2013-07-03 | — | — | EP | disclosed |
| US-20130137881-A1 | METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2013-05-30 | — | — | US | disclosed |
| CN-103080099-A | Method for producing a methylene disulfonate compound | SUMITOMO SEIKA CHEMICALS | 2013-05-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12129239-B2 | Method for producing methylene disulfonate compound | TST, MPST, SQOR | APP 4724/4885PTGS1 1297/4885PDE4A 4430/4885 |
| US-20130137881-A1 | METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND | DHPS, ADH7, MPST | APP 4300/4885PTGS1 1332/4885PDE4A 4339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.